texas oncology more breakthroughs. more victories

Share:

 
 

Vivek S. Kavadi, M.D., FASTRO, to be honored by the American Society for Radiation Oncology

August 07, 2019

Our own Vivek S. Kavadi, M.D., FASTRO, of Texas Oncology–Deke Slayton Cancer Center and Sugar Land is being honored by the American Society for Radiation Oncology (ASTRO) and named a fellow. This distinction recognizes his leadership, service, research, patient care, and education contributions to ASTRO and the field of radiation oncology. We asked Dr. Kavadi to share his perspectives on the role and the future of radiation in cancer treatment. 

What are the most important trends in radiation oncology that you see?

Radiation oncology continues to see exciting new technological advances in treatment delivery including expanded uses of stereotactic treatments, and MRI-guided therapy and PET-guided therapy. Radiation therapy is becoming more efficient with shorter treatment courses and continues to provide a high value for cancer patients.

Immunotherapies and targeted therapies continue to advance, as well as innovative surgical techniques. What’s your view of the future for the role of radiation therapy in cancer care?

There are a few situations where a patient can be treated in two different ways that may be viewed as competitive with each other. However, for the most part, surgery, medical oncology, and radiation oncology are collaborative and complementary fields that work together to provide the best survival and functional outcome for cancer patients. I look forward to seeing the continued improvements in immunotherapy and targeted therapies that will provide an opportunity for greater synergy with radiation. 

What are the key benefits or advantages of receiving radiation treatment in our community-based practice at Texas Oncology?

The key benefits come from integrated care, seamless coordination, and patient experience. Quality of care is paramount, but an important secondary benefit is that we are best positioned to provide the most efficient and cost-effective care.

You’ve been recognized by ASTRO for your leadership and contributions to radiation oncology. Quite an honor! What would you want patients to know about you and your approach to patient care?

When I left academia years ago, I did so with a desire to deliver high-quality care, continue to contribute to the field, and to provide meaningful leadership when the opportunity arose. My passion for patient care is also as strong as ever. 

Any other reflections on this important recognition? 

Fellowship has mostly been awarded to radiation oncologists in academic medicine. Very few private practice doctors have been recognized. This is both a gratifying and humbling experience. I would like to thank my mentors and colleagues who have helped me grow through the years, and of course the unwavering support of my family has been critical to any professional achievement.


For upcoming webinars visit www.TexasOncologyFoundation.org